mTOR gene variant rs2295080 might be a risk factor for atherosclerosis in Iranian women with type 2 diabetes mellitus
BMC Endocrine Disorders · 29.08.2024 · 24 (1)
DOI: 10.1186/s12902-024-01703-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMC Endocrine Disorders, online erschienen am 29.08.2024. Verfasst von Afsaneh Zare und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Atherosclerosis, Polymorphism, Single Nucleotide, Genetic Predisposition to Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shiraz University of Medical Sciences.
Themen: Diabetes mellitus
Abstract (Originalsprache)
BACKGROUND: Type 2 diabetes mellitus, one of the most prevalent metabolic disorders worldwide, is closely linked with an enhanced risk of atherosclerosis. However, the molecular mechanism of this linkage is not still clear. Genetic variations in the mTOR gene may increase the susceptibility of individuals to these diseases. METHODS: One hundred nine diabetic patients and 375 healthy subjects participated in this study. mTOR Single Nucleotide Polymorphism (SNP) rs2295080 was determined using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP). RESULTS: Comparison of genotypic, allelic, and genotypic combination frequencies between cases and controls revealed no significant result. Nevertheless, the frequency of rs2295080 GT + TT genotype was significantly more in diabetic women with atherosclerosis compared with those without atherosclerosis (p = 0.047). Besides, the rs2295080 G allele was more frequently detected in diabetic women without atherosclerosis compared to those with atherosclerosis (p = 0.046). CONCLUSION: The rs2295080 GT + TT genotype predisposes Iranian diabetic women to atherosclerosis, while the rs2295080 G allele protects them against atherosclerosis. However, additional experiments using larger sample sizes are needed to verify this result.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
- Cardiovascular Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
- Department of Cardiology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
- Autoimmune Diseases Research Center, School of Medicine, Shiraz University of Medical Sciences, PO Box: 71345-1583, Shiraz, Iran. Daryabor_gh@sums.ac.ir.
- Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. mdoroud@sums.ac.ir.
Förderung
- Shiraz University of Medical Sciences
Zitieren
APA
Zare, A., Khosropanah, S., Daryabor, G., & Doroudchi, M. (2024). mTOR gene variant rs2295080 might be a risk factor for atherosclerosis in Iranian women with type 2 diabetes mellitus. BMC Endocrine Disorders, 24(1). https://doi.org/10.1186/s12902-024-01703-4
Vancouver
Zare A, Khosropanah S, Daryabor G, Doroudchi M. mTOR gene variant rs2295080 might be a risk factor for atherosclerosis in Iranian women with type 2 diabetes mellitus. BMC Endocrine Disorders. 2024;24(1). doi:10.1186/s12902-024-01703-4
BibTeX
@article{Zare2024,
author = {Zare, Afsaneh and Khosropanah, Shahdad and Daryabor, Gholamreza and Doroudchi, Mehrnoosh},
title = {mTOR gene variant rs2295080 might be a risk factor for atherosclerosis in Iranian women with type 2 diabetes mellitus},
journal = {BMC Endocrine Disorders},
year = {2024},
volume = {24},
number = {1},
doi = {10.1186/s12902-024-01703-4}
}
EUVIMED